Basel Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	3.04	1.95	1.22	1.56
Cash & Short-Term Investments	3.04	1.95	1.22	1.56
Cash Growth	56.04%	60.26%	-22.14%	-
Accounts Receivable	9.49	2.01	1.58	2.28
Other Receivables	-	10.56	11.88	11.75
Total Trade Receivables	9.49	12.56	13.46	14.03
Inventory	0.49	0.07	0.09	0.07
Other Current Assets	0.27	1.59	-	-
Total Current Assets	13.29	16.17	14.77	15.67
Net Property, Plant & Equipment	5.34	0.06	0.58	1.18
Other Long-Term Assets	0.05	0.08	0.03	0
Total Assets	18.68	16.31	15.38	16.85
Accounts Payable	6.57	2.58	2.19	2.41
Accrued Expenses	-	0.44	0.48	0.39
Current Portion of Long-Term Debt	2.12	2.71	3.79	4.2
Other Current Liabilities	1.47	1.44	0.02	0.19
Total Current Liabilities	10.16	7.16	6.47	7.19
Long-Term Debt	2.96	1.58	3.42	5.95
Other Long-Term Liabilities	0.12	-	-	-
Total Long-Term Liabilities	3.08	1.58	3.42	5.95
Total Liabilities	13.24	8.75	9.89	13.14
Common Stock	34.21	24.46	0	0
Additional Paid-in Capital	-24.46	-24.46	-	-
Accumulated Other Comprehensive Income	-0.46	-	-	-
Retained Earnings	-3.85	7.56	5.49	3.71
Total Common Shareholders' Equity	5.43	7.56	5.49	3.71
Minority Interest	0	-	-	-
Shareholders' Equity	5.44	7.56	5.49	3.71
Total Liabilities & Equity	18.68	16.31	15.38	16.85
Total Debt	5.08	4.29	7.21	10.15
Net Cash (Debt)	-2.03	-2.34	-6	-8.59
Net Cash Per Share	-0.11	-0.14	-0.37	-0.53
Book Value	5.43	7.56	5.49	3.71
Book Value Per Share	0.29	0.47	0.34	0.23
Tangible Book Value	5.43	7.56	5.49	3.71
Tangible Book Value Per Share	0.29	0.47	0.34	0.23

SEC Filings: 10-K · 10-Q